286 related articles for article (PubMed ID: 17616301)
1. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
[TBL] [Abstract][Full Text] [Related]
2. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
El Harchaoui K; van der Steeg WA; Stroes ES; Kuivenhoven JA; Otvos JD; Wareham NJ; Hutten BA; Kastelein JJ; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2007 Feb; 49(5):547-53. PubMed ID: 17276177
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.
Birjmohun RS; Dallinga-Thie GM; Kuivenhoven JA; Stroes ES; Otvos JD; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
Circulation; 2007 Oct; 116(18):2029-35. PubMed ID: 17923573
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Keller TT; Choi D; Nagel C; Te Velthuis H; Gerdes VE; Wareham NJ; Bingham SA; Luben R; Hack CE; Reitsma PH; Levi M; Khaw KT; Boekholdt SM
J Thromb Haemost; 2006 Nov; 4(11):2391-6. PubMed ID: 16938131
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein particle size and concentration and coronary risk.
El Harchaoui K; Arsenault BJ; Franssen R; Després JP; Hovingh GK; Stroes ES; Otvos JD; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
Ann Intern Med; 2009 Jan; 150(2):84-93. PubMed ID: 19153411
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Rip J; Nierman MC; Wareham NJ; Luben R; Bingham SA; Day NE; van Miert JN; Hutten BA; Kastelein JJ; Kuivenhoven JA; Khaw KT; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):637-42. PubMed ID: 16373616
[TBL] [Abstract][Full Text] [Related]
7. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
[TBL] [Abstract][Full Text] [Related]
9. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.
Tsimikas S; Mallat Z; Talmud PJ; Kastelein JJ; Wareham NJ; Sandhu MS; Miller ER; Benessiano J; Tedgui A; Witztum JL; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2010 Sep; 56(12):946-55. PubMed ID: 20828647
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study.
Holleboom AG; Kuivenhoven JA; Vergeer M; Hovingh GK; van Miert JN; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
J Lipid Res; 2010 Feb; 51(2):416-21. PubMed ID: 19671930
[TBL] [Abstract][Full Text] [Related]
12. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Boekholdt SM; Peters RJ; Hack CE; Day NE; Luben R; Bingham SA; Wareham NJ; Reitsma PH; Khaw KT
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1503-8. PubMed ID: 15178568
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
Heslop CL; Frohlich JJ; Hill JS
J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
Kimak E; Zięba B; Duma D; Solski J
Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.
Boekholdt SM; Hack CE; Sandhu MS; Luben R; Bingham SA; Wareham NJ; Peters RJ; Jukema JW; Day NE; Kastelein JJ; Khaw KT
Atherosclerosis; 2006 Aug; 187(2):415-22. PubMed ID: 16257408
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Boekholdt SM; Meuwese MC; Day NE; Luben R; Welch A; Wareham NJ; Khaw KT
Br J Nutr; 2006 Sep; 96(3):516-22. PubMed ID: 16925857
[TBL] [Abstract][Full Text] [Related]
19. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
